The factor V Leiden mutation and risk of renal vein thrombosis in patients with nephrotic syndrome

Nephrology Dialysis Transplantation

Volumn 12, Issue 8, 1997, Pages 1680-1683

  Irish, Ashley B ^a,b  

^a CHURCHILL HOSPITAL   (United Kingdom)

^b ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Factor V Leiden mutation; Nephrotic syndrome; Renal vein thrombosis

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; GENE MUTATION; HUMAN; KIDNEY VEIN THROMBOSIS; MALE; NEPHROTIC SYNDROME; PATHOGENESIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; AGED; FACTOR V; FEMALE; GENOTYPE; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; MUTATION; NEPHROTIC SYNDROME; RENAL VEINS; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOSIS;

EID: 0030788234     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/12.8.1680     Document Type: Article

References (20)

1. Llach F. Hypercoagulability, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome. Kidney Int 1985; 28: 429-439
2. Cameron JS. Coagulation and Thromboembolic Complications in the Nephrotic Syndrome. Advances in Nephrology. Year Book Medical Publishers, Inc, 1984; vol 13: 75-114
3. Zwaginga JJ, Koomans HA, Sixma LL, Rabelink TJ. Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions. J Clin Invest 1994; 93: 204-211
4. Rabelink TJ, Zwaginga JJ, Koomans HA, Sixma JJ. Thrombosis and hemostasis in renal disease. Kidney Int 1994; 46: 287-296
5. Sagripanti A, Barsotti G. Hypercoagulability, intraglomerular coagulation, and thromboembolism in nephrotic syndrome. Nephron 1995; 70: 271-281
6. Chen TY, Huang CC, Tsao CJ. Hemostatic molecular markers in nephrotic syndrome. Am J Hematol 1993; 44: 276-279
7. Nachman RL, Silverstein R. Hypercoagulable states. Ann Intern Med 1993; 119:819-827
8. Svensson PJ, Dahlbäck B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994; 330(8): 517-522
9. Bertina RM, Koeleman BP, Koster T et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369; 64-67
10. Bertina RM, Reitsma PH, Rosendaal F, Vandenbroucke JP. Resistance to activated protein C and factor V Leiden as risk factors for venous thrombosis. Thromb Haemost 1995; 74(1): 449-453
11. Vandenbroucke JP, Koster T, Bri't E, Reitsma PH, Bertina RM, Rosendaal FR. Increased risk of venous thrombosis in oral contraceptive users who are carriers of the factor V Leiden mutation. Lancet 1994; 344: 1453-1457
12. Ridker PM, Hennekens CH, Lindpainter K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 1995; 332: 912-917
13. Montinaro V, Coccheri S, Palareti G et al. Association of membranous nephropathy with familial resistance to activated protein C. Nephrol Dial Transplant 1995; 10: 2133-2136
14. Talmud P, Tyæberg-Hansen A, Bhatnagar D et al. Rapid screening for specific mutations in patients with a clinical diagnosis of familial hypercholesterolaemia. Atherosclerosis 1991; 89: 137
15. Ridker PM, Miletich JP, Stampfer MJ, Goldhaber SM, Lindpaintner K, Hennekens CH. Factor V Leiden and risks of recurrent idiopathic venous thromboembolism. Circulation 1995; 92(10): 2800-2802
16. Dahlbäck B. New molecular insights into the genetics of thrombophilia. Resistance to activated protein C caused by Arg506 to Gln mutation in factor V as a pathogenic risk factor for venous thrombosis. Thromb Haemost 1995; 74(1): 139-148
17. Hajjar KA. Factor V Leiden-an unselfish gene? N Engl J Med 1994; 331(23): 1585-1587
18. Dahlbäck B. Are we ready for factor V Leiden screening? Lancet 1996; 347: 1346-1347
19. Vandenbroucke JP, van der Meer FJM, Helmerhorst FH, Rosendaal FR. Factor V Leiden: should we screen oral contraceptive users and pregnant women? Br Med J 1996; 313: 1127-1130
20. Denninger MH, Beldjord K, Durand F, Denié C, Valla D, Guillin M-C. Budd-Chiari syndrome and factor V Leiden mutation. Lancet 1995; 345: 525-526